The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Carcinoembryonic Antigen (CEA)-Global Market Insights and Sales Trends 2024
Synopsis
Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion.
The global Carcinoembryonic Antigen (CEA) market size is expected to reach US$ 2328 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Carcinoembryonic Antigen (CEA) in various end use industries. The expanding demands from the Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer and Breast Cancer, are propelling Carcinoembryonic Antigen (CEA) market. CD66a, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the CD66b segment is estimated at % CAGR for the next seven-year period.
Increasing consumption of alcohol and sedentary lifestyle are likely to boost the growth of colorectal cancer over the forecast period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Carcinoembryonic Antigen (CEA), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Carcinoembryonic Antigen (CEA) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Carcinoembryonic Antigen (CEA) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Carcinoembryonic Antigen (CEA) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Carcinoembryonic Antigen (CEA) covered in this report include Roche Diagnostics, Abbott Diagnostics and Quest Diagnostics, etc.
The global Carcinoembryonic Antigen (CEA) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche Diagnostics
Abbott Diagnostics
Quest Diagnostics
Global Carcinoembryonic Antigen (CEA) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Carcinoembryonic Antigen (CEA) market, Segment by Type:
CD66a
CD66b
CD66c
CD66d
CD66e
CD66f
Global Carcinoembryonic Antigen (CEA) market, by Application
Colorectal Cancer
Pancreatic Cancer
Ovarian Cancer
Breast Cancer
Thyroid Cancer
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Carcinoembryonic Antigen (CEA) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion.
The global Carcinoembryonic Antigen (CEA) market size is expected to reach US$ 2328 million by 2029, growing at a CAGR of 4.1% from 2023 to 2029. The market is mainly driven by the significant applications of Carcinoembryonic Antigen (CEA) in various end use industries. The expanding demands from the Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer and Breast Cancer, are propelling Carcinoembryonic Antigen (CEA) market. CD66a, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the CD66b segment is estimated at % CAGR for the next seven-year period.
Increasing consumption of alcohol and sedentary lifestyle are likely to boost the growth of colorectal cancer over the forecast period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Carcinoembryonic Antigen (CEA), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Carcinoembryonic Antigen (CEA) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Carcinoembryonic Antigen (CEA) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Carcinoembryonic Antigen (CEA) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Carcinoembryonic Antigen (CEA) covered in this report include Roche Diagnostics, Abbott Diagnostics and Quest Diagnostics, etc.
The global Carcinoembryonic Antigen (CEA) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche Diagnostics
Abbott Diagnostics
Quest Diagnostics
Global Carcinoembryonic Antigen (CEA) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Carcinoembryonic Antigen (CEA) market, Segment by Type:
CD66a
CD66b
CD66c
CD66d
CD66e
CD66f
Global Carcinoembryonic Antigen (CEA) market, by Application
Colorectal Cancer
Pancreatic Cancer
Ovarian Cancer
Breast Cancer
Thyroid Cancer
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Carcinoembryonic Antigen (CEA) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Carcinoembryonic Antigen (CEA)
1.1 Carcinoembryonic Antigen (CEA) Market Overview
1.1.1 Carcinoembryonic Antigen (CEA) Product Scope
1.1.2 Carcinoembryonic Antigen (CEA) Market Status and Outlook
1.2 Global Carcinoembryonic Antigen (CEA) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Carcinoembryonic Antigen (CEA) Market Size by Region (2018-2029)
1.4 Global Carcinoembryonic Antigen (CEA) Historic Market Size by Region (2018-2023)
1.5 Global Carcinoembryonic Antigen (CEA) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Carcinoembryonic Antigen (CEA) Market Size (2018-2029)
1.6.1 North America Carcinoembryonic Antigen (CEA) Market Size (2018-2029)
1.6.2 Europe Carcinoembryonic Antigen (CEA) Market Size (2018-2029)
1.6.3 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size (2018-2029)
1.6.4 Latin America Carcinoembryonic Antigen (CEA) Market Size (2018-2029)
1.6.5 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size (2018-2029)
2 Carcinoembryonic Antigen (CEA) Market by Type
2.1 Introduction
2.1.1 CD66a
2.1.2 CD66b
2.1.3 CD66c
2.1.4 CD66d
2.1.5 CD66e
2.1.6 CD66f
2.2 Global Carcinoembryonic Antigen (CEA) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Carcinoembryonic Antigen (CEA) Historic Market Size by Type (2018-2023)
2.2.2 Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Carcinoembryonic Antigen (CEA) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Carcinoembryonic Antigen (CEA) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Carcinoembryonic Antigen (CEA) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Carcinoembryonic Antigen (CEA) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Carcinoembryonic Antigen (CEA) Revenue Breakdown by Type (2018-2029)
3 Carcinoembryonic Antigen (CEA) Market Overview by Application
3.1 Introduction
3.1.1 Colorectal Cancer
3.1.2 Pancreatic Cancer
3.1.3 Ovarian Cancer
3.1.4 Breast Cancer
3.1.5 Thyroid Cancer
3.1.6 Others
3.2 Global Carcinoembryonic Antigen (CEA) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Carcinoembryonic Antigen (CEA) Historic Market Size by Application (2018-2023)
3.2.2 Global Carcinoembryonic Antigen (CEA) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Carcinoembryonic Antigen (CEA) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Carcinoembryonic Antigen (CEA) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Carcinoembryonic Antigen (CEA) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Carcinoembryonic Antigen (CEA) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Carcinoembryonic Antigen (CEA) Revenue Breakdown by Application (2018-2029)
4 Carcinoembryonic Antigen (CEA) Competition Analysis by Players
4.1 Global Carcinoembryonic Antigen (CEA) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Carcinoembryonic Antigen (CEA) as of 2022)
4.3 Date of Key Players Enter into Carcinoembryonic Antigen (CEA) Market
4.4 Global Top Players Carcinoembryonic Antigen (CEA) Headquarters and Area Served
4.5 Key Players Carcinoembryonic Antigen (CEA) Product Solution and Service
4.6 Competitive Status
4.6.1 Carcinoembryonic Antigen (CEA) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche Diagnostics
5.1.1 Roche Diagnostics Profile
5.1.2 Roche Diagnostics Main Business
5.1.3 Roche Diagnostics Carcinoembryonic Antigen (CEA) Products, Services and Solutions
5.1.4 Roche Diagnostics Carcinoembryonic Antigen (CEA) Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Diagnostics Recent Developments
5.2 Abbott Diagnostics
5.2.1 Abbott Diagnostics Profile
5.2.2 Abbott Diagnostics Main Business
5.2.3 Abbott Diagnostics Carcinoembryonic Antigen (CEA) Products, Services and Solutions
5.2.4 Abbott Diagnostics Carcinoembryonic Antigen (CEA) Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Diagnostics Recent Developments
5.3 Quest Diagnostics
5.3.1 Quest Diagnostics Profile
5.3.2 Quest Diagnostics Main Business
5.3.3 Quest Diagnostics Carcinoembryonic Antigen (CEA) Products, Services and Solutions
5.3.4 Quest Diagnostics Carcinoembryonic Antigen (CEA) Revenue (US$ Million) & (2018-2023)
5.3.5 Recent Developments
6 North America
6.1 North America Carcinoembryonic Antigen (CEA) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Carcinoembryonic Antigen (CEA) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Carcinoembryonic Antigen (CEA) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Carcinoembryonic Antigen (CEA) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Carcinoembryonic Antigen (CEA) Market Dynamics
11.1 Carcinoembryonic Antigen (CEA) Industry Trends
11.2 Carcinoembryonic Antigen (CEA) Market Drivers
11.3 Carcinoembryonic Antigen (CEA) Market Challenges
11.4 Carcinoembryonic Antigen (CEA) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
